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Metastatic liver resection following cytoreductive chemotherapy is an accepted treatment for oligometastatic tumor diseases.
Although pulmonary complications are frequently reported in patients undergoing liver surgery including liver transplantation,
life-threatening acute respiratory failures in the absence of aspiration, embolism, transfusion-related acute lung injury (TRALI),
pulmonary infection, or an obvious source of systemic sepsis are rare. We performed an extensive clinical review of a patient
undergoing metastatic liver resection who had a clinical course compatible to an acute respiratory distress syndrome (ARDS)
without an obvious cause except for the surgical procedure and multiple preoperative chemotherapies. We hypothesize that either
the surgical procedure mediated by cytokines and tumor necrosis factor or possible toxic eﬀects of oxygen applied during general
anesthesia were associated with life-threatening respiratory failure in the patient. Discrete and subclinical inﬂammated alveoli
(probably due to multiple preoperative chemotherapies with substances at potential risk for interstitial pneumonitis as well as
chest radiation) might therefore be considered as risk factors.
1.CaseReport
A 65-year-old, nonsmoking female patient (68kg, 153cm)
was diagnosed with breast cancer (pT1c pN1b [2/25] cM0,
G3, oestrogen receptor positive) of the left breast in the
year 1994. In September 2009, the patient was presented
for metastatic liver resection (S4a). The detailed history
is presented in Table 1 whereas the patient’s concomitant
diseases and risk factors are presented in Table 2.T h e
preoperativeelevationrevealedanunobtrusivelungfunction
(VC, vital capacity: 2.31L; FEV1, Forced expiratory vital
capacity within 1 second: 2.18L). In addition, preoperative
chest X-ray showed no conspicuities (Figure 1). Accordingly,
the patient was prepared for left-sided hemihepatectomy
using a combined anesthesiological procedure (general anes-
thesia in combination with a thoracic epidural catheter).
The ﬁrst arterial blood gas analysis revealed a suﬃcient
pulmonaryfunctionwithoutanyindicationforanupcoming
pulmonary complication (FIO2 0.6, PaO2 308.5mmHg,
PaCO2 42.9mmHg, HCO3 32.9mmol/L, BE 8.8mmol/L).
Approximately 90 minutes after induction of general anes-
thesia during the surgical phase of ongoing liver preparation,
a stepwise decrease of the peripheral oxygen saturation
(minimum 94%) under constant ventilator settings (FIO2
0.44, VR 12/min, VT 450mL, PEEP 3mbar) became evident.
Pulmonaryauscultationrevealedtwo-sidedventilationofthe
lungs with discrete inspiratory rales on both sides. Further-
more an arterial blood gas analysis was performed, showing
a signiﬁcantly decreased arterial oxygen partial pressure
(PaO2 68.8mmHg).Underastepwiseincreaseoftheinspired
o x y g e nf r a c t i o nu pt oF I O 2 1.0, the following measures were
performed, but only led to short-term improvements.2 Anesthesiology Research and Practice
Table 1: Anamnesis.
December 1994
Diagnosis of breast cancer followed
by a resection of the left breast
January 1995–June 1995
Adjuvant chemotherapy
(cyclophosphamide, metothrexate,
5-ﬂuoruracil)
January 1995–June 2005 Tamoxifen
June 2005
Diagnosis and extirpation of a
lymph node metastasis in the left
supraclavicular area
July 2005–September
2005
Radiation of the left supraclavicular
area
December 2005
Diagnosis of a metastasis in the
ventral part of the mediastinum
with an osteolytic destruction of the
breastbone
January 2006–February
2006
Radiation of the mediastinum
March 2006 D i a g n o s i so fal i v e rm e t a s t a s i s( S 4 a )
March 2006–July 2006
Chemotherapy (trastuzumab,
docetaxel) was followed by a
complete remission of the
metastasis
July 2006–October 2008 Monotherapy with trastuzumab
October 2008
Reappearance of the liver metastasis
with a dimension increase
October 2008–March
2009
Chemotherapeutics were escalated
towards lapatinib and capecitabine
March 2009–August
2009
Dimension decrease of the liver
metastasis. Monotherapy with
lapatinib due to capecitabine
associated hemorrhagic diarrhea.
September 2009
Left-sided hemihepatectomy
followed by an ARDS
(i) Open lung ventilation (Recruitment Maneuver).
(ii) Lungs were sucked oﬀ (small amounts of a clear
secretion).
(iii) Diuretics were applied due to an insuﬃcient diuresis
in the initial phase of the surgical procedure.
(iv) Prophylactic antiallergic therapy (single shot of
500mg prednisolone, antihistaminic blockade).
Beside pulmonary problems, the patient further revealed
instability of the circulatory system requiring an increased
vasopressor and ﬂuid administration during the surgical
phase of liver resection. A further arterial blood gas
analysis conﬁrmed persisting hypoxemia (FIO2 1.0; PaO2
86.3mmHg) in combination with slightly increasing PaCO2-
values (PaCO2 45.4mmHg) under constant endexpira-
tory CO2-values (PetCO2 33mmHg). A transoesophageal
echocardiographywasperformedimmediatelyafteranaccel-
erated end of the surgical procedure. Beside the preexisting
combined aortic valve defect (stenosis > insuﬃciency), no
other newly developed valve defects such as pulmonary
Table 2: The patient’s concomitant diseases.
Essential arterial hypertension
Combined aortic valve defect (stenosis > insuﬃciency)
Essential hyperlipoproteinemia
Rheumatoid Arthritis under corticosteroid treatment (5mg
prednisone/die)
Diabetes mellitus II (Insulin-dependent)
Nodular goiter (euthyroid)
insuﬃciencyortricuspidvalveinsuﬃciencybecameobvious.
Above all, both ventricles showed a normal conﬁguration,
without any signs of ventricular dysfunction.
Duetoaprogressingdeteriorationofthepatient’scardio-
circulatory and pulmonary conditions, in order to achieve
further information a computed tomography of the chest
was performed. The tomography of the chest showed typical
signs for an acute respiratory distress syndrome (ARDS)
whereas no signs for a pulmonary embolism were detected
(Figure 2). After admission to the ICU, the respiratory
situation remained critical, so the inhalation of nitric oxide
was started. In addition, the patient received a high-dose
corticosteroid regime (hydrocortisone 600mg/24h) for 5
days. No signs for an infection became obvious, as assessed
by low-peak plasma levels of c-reactive protein (88.5mg/L)
and procalcitonin (0.06ng/mL) one day after ARDS-onset.
Furthermore, during initial ICU-stay microbiological inves-
tigations (tracheal secretions, hemoculture) did not reveal
any sign for an infectious procedure.
The following days an attempt was made to avoid an
excessive ﬂuid management. Prone positioning or surfactant
replacement were discussed as therapeutical options but not
realized due to a suﬃcient advancement of the respira-
tory conditions within the ﬁrst hours after corticosteroid
administration. Therefore, therapy with inhaled nitric oxide
could already be ﬁnished eight hours after ARDS-onset.
Despite a perioperative thrombosis prophylaxis on the
ICU (UFH 10.000IU/24h), a newly developed pulmonary
embolism (without a hemodynamic relevance) could be
diagnosed by a computer tomography scan three days after
ARDS-onset. As a result from this point on the patient
received a full anticoagulation with UFH (25.000IU/24h).
Duplex sonography was negative for deep vein throm-
bosis. Apart from this pulmonary embolism, as well as
an increasing pleural eﬀusion with the need for a chest
tube, the weaning procedure was successful (Figure 3). Four
days after ARDS-onset, the ﬁrst attempt for an extuba-
tion was performed. Furthermore, corticosteroid therapy
was reduced to the patient’s preoperative corticosteroid
application scheme due to rheumatoid arthritis (prednisone
5mg/die).
Unfortunately, 24 hours after the initial extubation (5
days after ARDS-onset) the patient provided a respiratory
deterioration with the need for a reintubation accompanied
by a sudden increase of c-reactive protein and leucocytes.
In response, an antibiotic therapy was initiated and the
central venous catheter was changed. Afterwards the patientAnesthesiology Research and Practice 3
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Figure 1: Chest X-ray diagnostic in the patient from preoperative (Pre-OP) until closely to the patient’s discharge from hospital at day 14.
Pre-OP: preoperative; d: day; ap: anterior-posterior; lat: lateral.
revealed a rapid amelioration of the respiratory conditions;
at the same time plasma levels of c-reactive protein and
leucocytes declined. The next attempt for an extubation was
delayed due to an inadequate awakening. Finally, extubation
was performed successfully 10 days after ARDS-onset. In
the next days, the patient showed a favorable outcome.
Counting from ARDS-onset, she was eligible for the transfer
to intermediate care after 13 days and for her discharge from
hospital after 18 days.
2. Discussion
Perioperative deterioration of pulmonary function repre-
sents a potentially life-threatening complication with the
need for a fast and trigger-based therapy. Many triggers have
to be taken into account in the case of acute perioperative
lung failure.
2.1.DislocationoftheEndotrachealTube/Pneumothorax. Dis-
location of the endotracheal tube, as well as diaphragmatic
lesions in the course of surgery leading to a pneumothorax
can result in acute perioperative deterioration of the respi-
ratory system. Especially surgical procedures in the upper
abdominal area (e.g., surgery of the liver, kidneys or the
spleen) are known to be at high risk for diaphragmatic
injuries [1]. In both cases, a one-sided breath sound can be
anticipated. Due to both-sided breath sounds in our patient
as assessed by a repeated and intensive auscultation of the
chest, as well as the absence of a diaphragmatic lesion, tube
dislocation and pneumothorax could be excluded.
2.2. Aspiration. 1.4–5.0 per 10.000 patients undergoing
general anesthesia sustain a perioperative aspiration with
a morbidity of 0.6–1.0 per 10.000 and a letality of 1.0–
2.2 per 100.000 anesthesiological procedures. In total 10%–
30% of anesthesia associated deaths can be attributed
to complications of aspiration syndrome [2–4]. Especially
patients undergoing emergency surgical procedures, as well
as patients with gastric contents or other predisposing risk
factors (e.g., obesity, reﬂux disease, etc.) are at high risk
for perioperative aspiration. Due to an unobtrusive risk
proﬁle, a problem-free orotracheal intubation procedure (no
prolonged phases of mask ventilation with the risk of gastric
air insuﬄation, continuous cuﬀ pressure levels between 25–
30cmH2O at all times) as well as successful placement
of a stomach tube, aspiration as the main cause of acute
respirators failure remains less likely.
2.3. Atelectasis. Due to a low-PEEP-ventilation regime,
patients undergoing liver resections are at high risk for
atelectatic alterations of the lungs [1]. Therefore a Recruit-
ment Maneuver was performed after the onset of pulmonary
deterioration. Afterwards a best-PEEP-ventilation regime
according to the ARDS SepNet-Protocol was continued.
Unfortunately, none of these eﬀorts was able to optimize the
patient’s oxygenation. Therefore, the diagnosis of atelectasis-
associated respiratory failure also is less likely.4 Anesthesiology Research and Practice
Computed tomography of chest (d0 / in axial cut): typical ground glass opaciﬁcation sparing the apical part of the upper lobe with
a hazy increase in lung attenuation with preservation of bronchial and vascular margins. Reticular pattern in apical part of the upper
lobe. In lower lobe domination of a consolidation with a more or less homogenous increase in lung attenuation and positive
air-bronchogramm in the lower left lobe. Pleural eﬀusion and atelektasis present in dorso-basal part of the lower lobe.
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Computed tomography of chest (d0 / in coronary cut): no signs for pulmonary embolisms.
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Figure 2: Coronary and axial cuts of the computed tomography of the chest immediately after the end of surgery before patient’s admission
to the intensive care unit. d: day.
2.4. Pulmonary Embolism. According to decreased central
venouspressureasaneﬀectofarestrictiveﬂuidmanagement
and a low-PEEP-ventilation regime, surgical procedures
involving the liver may be at high risk for embolisms (gas,
tumor, etc.) [5, 6]. Furthermore, the clinical symptoms
“severehypoxemia,increasingPaCO2 values,andprogressive
hemodynamic instability” support the hypothesis of pul-
monary embolism. Unfortunately, this hypothesis had to be
rejected,sinceatransoesophagealechocardiographyrevealed
no signs for a right ventricular dilatation/dysfunction as
well as no newly developed valve defects such as pulmonary
insuﬃciency or tricuspid valve insuﬃciency.
2.5. Cardiac Ischemia, Left Atrial Hypertension, Pulmonary
Edema. Perioperative cardiac ischemia represents one of the
most important risk factors for increased morbidity and
mortality in the perioperative setting [7, 8]. Depending on
individual risk factors, the intended surgical procedure as
well as the underlying diagnostic criteria, the incidence of
perioperative cardiac ischemia ranges from 4.5% to 78.0%
and can mainly be observed in the early postoperative phase
[8–14]. Therefore, perioperative left-ventricular ischemia
leading to a left-sided cardiac dysfunction may be consid-
ered as a possible trigger for acute respiratory failure in
patients undergoing major abdominal surgery. Due to a
negative patient history for coronary artery disease and lack
of echocardiographic signs for cardiac ischemia (regional
disturbances of cardiac wall movements, left atrial hyper-
tension), the diagnosis of pulmonary edema due to a left
ventricular dysfunction became unlikely.
2.6. Transfusion Associated Lung Injury (TRALI). With an
incidence ranging from 1:2.000 to 1:5.000, transfusions
of plasma containing blood products are known to be
associated with the development of an acute lung injury
due to donor-speciﬁc antibodies against granulocytes of
the host [15]. It is deﬁned as acute noncardiac hypox-
emia/breathlessness in association with newly developed
bilateral lung inﬁltrates within 6 hours after the transfusion.
Because our patient did not receive any plasma contain-
ing blood products, the diagnosis of TRALI had to be
rejected.Anesthesiology Research and Practice 5
Computed tomography of chest (d3 / in axial cut): increase of ventilation in the dependent parts of the lung. Persistent pleural
eﬀusion and atelektasis in the dorso-basal part of the lower lobe. Residual ground glass pattern in the middle lung.
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Figure 3: Coronary and axial cuts of the computed tomography of the chest at day 3 after onset of ARDS. d: day; ARDS: acute respiratory
distress syndrome.
2.7. Transfusion Associated Circulatory Overload (TACO).
Acute hypoxemia, breathlessness, and tachypnea also appear
as characteristic clinical signs for a TACO due to the
development of a hydrostatic pulmonary edema within 6
hoursfollowingexcessiveperioperativevolumeoverload[16,
17]. To distinguish between TRALI and TACO can cause
some diﬃculties. In case of a TACO increasing levels of
central venous pressure and pulmonary arterial pressure,
a tachycardia as well as a hypertonic derailment can be
observed [16, 17]. In the literature, the incidence of TACO
is reported to be between 1:356 and 1:3.000. Especially
patients with preexisting cardiac diseases (e.g., cardiac
insuﬃciency or coronary artery heart disease) seem to be at
risk. Due to negative history for active cardiac conditions, a
restrictive perioperative volume replacement regime without
any transfusions as well as a normal transoesophageal
echocardiography, the diagnosis of a TACO also had to be
rejected.
Unfortunately, despite intensive diagnostics, the reason
for respiratory failure in this patient remains unknown.
Therefore, a computed tomography of the chest was per-
formed. Although the diagnosis of an acute respiratory dis-
tress syndrome (ARDS) was pointed out by the radiologist,
the inducing trigger further remained unknown.
Some of the disorders associated with ARDS such as
presented in Table 3 (e.g., aspiration, transfusion associated
lunginjury,embolism,etc.)werealreadyexcludedatbedside,
so that three further triggers were now critically discussed.
2.8. Sepsis, Pneumonia. Infection-related disorders such as
severe sepsis and/or septic shock are frequently associated
with the occurrence of an ARDS. The SepNet trial revealed
a prevalence of severe sepsis/septic shock of 11% and a
resulting mortality of 48% on intensive care units. Therefore,
severe sepsis/septic shock are the most common causes of
death in noncardiologic intensive care medicine. In most6 Anesthesiology Research and Practice
Table 3: Disorders associated with the acute respiratory distress
syndrome (ARDS).
Sepsis (most common)
Aspiration
Pneumonia (bacterial, viral, fungal, etc.)
Embolism (VTE, amniotic, tumor, etc.)
Hematologic (transfusion-related acute lung injury, TRALI)
Shock (any etiology)
Trauma
Acute pancreatitis
Drugs (amiodarone, tocolytics, salicylates, opiates, etc.)
Reperfusion injury (post-lung transplant, lung reexpansion)
Acute upper airway obstruction
Neurogenic pulmonary edema
cases, an infection of the respiratory tract (63%) or an
intraabdominal infection (25%) is found to be the focus
[18]. According to the ACCP/SCCM-Consensus Confer-
ence, sepsis is deﬁned by the presence of both infection
(documented or suspected) and a systemic inﬂammatory
response [19]. Due to low peak plasma levels of c-reactive
protein and procalcitonin, a normal leucocyte count as
well as negative microbiological investigations (tracheal
secretion, hemoculture) in the pre- and postoperative phase,
an infectious ARDS-focus (e.g., pneumonia) could not be
identiﬁed.
2.9. Respiratory Burst. Several chemotherapeutics such as
docetaxel, trastuzumab, lapatinib, gemcitabine, cisplatin,
busulfan/melphalan, bleomycin, and so forth, seem to be
associated with the development of a severe pneumonitis
leading to ARDS even though it represents a very rare side
eﬀect [20–30].
T h ep a t i e n tp r e s e n t e di nt h i sc a s er e p o r tr e c e i v e dd o c -
etaxel, trastuzumab, as well as lapatinib; accordingly the
patient was treated with potential pneumonitis inducing
agents. In addition, a chest radiation was performed twice.
In patients at high risk for preexisting inﬂammatory changes
of the lung, for example, pneumonitis or alveolitis, especially
the induction of general anesthesia using elevated inspired
oxygen fraction concentrations is known to contribute to
the onset of an acute respiratory distress syndrome (ARDS).
After induction, the preexisting endothelial dysfunction
causes cells and inﬂammatory exudates to enter the alveoli
with a concomitant increase of the thickness of the alveolo-
capillary space, leading to hypoxia and secondary induction
of ﬁbrosis of the airspace. In contrast to patients with hydro-
static pulmonary edema, in ARDS patients’ ﬂuid removal
from the alveolar space is impaired [31, 32]. Furthermore,
in patients with ARDS surfactant synthesis and function are
also reduced leading to decreased lung compliance [33–36].
In our patient, we suspected as a precursor for ARDS-
onset an acute exacerbation of a preexisting subclinical
pneumonitis. In contrast to the existing literature, our
patient developed symptoms of ARDS as early as two
hours after the induction of general anesthesia, although the
pulmonary status before and immediately after induction
of general anesthesia revealed no sign for an impairment as
assessed by a preoperative X-ray, preoperative spirometrical
investigation, and an arterial blood gas analysis after the
induction of general anesthesia. The rapid improvement
of lung oxygenation following corticosteroid administration
and the lack of bacterial, viral, or fungal infections of the
lungs may support our hypothesis of a hypersensitivity-
pneumonitis-based-ARDS with a good response to anti-
inﬂammatory therapeutic strategies.
2.10. Tumor-Associated Cytokine Storm. In the literature,
cases of ARDS following cytoreductive surgery have been
described [37, 38]. Eltabbakh and colleagues report of
a 58-year-old woman who developed ARDS following
extensive cytoreductive surgery for a widely disseminated
intraperitoneal leiomyosarcoma. It was concluded that the
onset of ARDS might be due to the massive cytoreductive
surgery probably mediated by cytokines and tumor necrosis
factor. Furthermore, multiple transfusions were discussed
as potential ARDS-inductors [38]. Alonso and colleagues
presented two patients who had a clinical course com-
patible with ARDS without obvious cause except for the
cytoreductive surgery, perioperative intraperitoneal as well
as intrapleural chemotherapy. These two patients developed
gradually increasing respiratory distress in the postoperative
period. No bacterial or fungal infections of lungs or intra-
abdominal sites or sepsis were discovered. It was concluded
that aggressive cytoreductive surgery along with periop-
erative chemotherapy was associated with life-threatening
respiratory failure in these two patients.
However, a left-sided hemihepatectomy as performed in
ourpatientcannotbedescribedasanextensivecytoreductive
surgery. The authors hypothesize that beside the amount
of cytoreduction, the perfusion of the manipulated tissue
might play an important role. The liver is known as one
of the organs with the best perfusion. About 25% of the
heart time volume circulates continuously through the liver
[39]. Therefore, liberation of cytokines and tumor necrosis
factor caused by surgical manipulations of tumorous liver
tissue during the preparation phase may lead to a rapid
systemic dissemination. After liberation of the cytokines into
the bloodstream, the lung represents one of the ﬁrst organs
getting in contact with these cytokines, resulting in dissem-
inated inﬂammation. This eﬀect might be perpetuated by
the preoperative application of multiple chemotherapeutics,
probably associated with an inﬂammatory preconditioning
of the lungs.
Conditions that initiated the sequences of events that
resulted in ARDS in our patient were not clearly asso-
ciated with the clinical conditions causing the syndrome
as described in the medical literature. Nevertheless, after
excluding most common other disorders associated with
ARDS (Table 3), the two disorders ﬁnally discussed here
remained the very likely causes for ARDS-induction in
the patient. At the same time, it still remains unclear
whether one of these pathways alone or a combination
of both contributed to the rapid onset of ARDS in our
patient.Anesthesiology Research and Practice 7
Inclusion criteria I: ARDS / ALI
Acute onset of severe respiratory distress syndrome
SOP “ARDS/ALI”
Basic therapeutical measures:
Intensiﬁed monitoring (arterial ∼ & central venous catheter, PICCO catheter)
Cardiocirculatory stabilization (PICCO guided: catecholaminergic support, volume load)
Pulmonary stabilization (non-invasive ventilation, intubation→invasive ventilation)
Transfer to intensive care unit (ICU)
Standard diagnostic procedures / inclusion criteria II:
Horowitz-index (PaO2/FiO2) < 300mmHg (ALI) / < 200mmHg (ARDS)
Chest-CT (ﬁrst line) / CHEST-X-Ray (second line):
Bilateral inﬁltrates (patchy, diﬀuse, or homogenous), consistent with pulmonary edema
Transthoracic/transesophageal echocardiography (ﬁrst line) / pulmonary arterial katheter (second line):
No clinical evidence of left atrial hypertension (TACO, cardiac ischemia, acute heart failure)
Think about: ARDS-Trigger
Sepsis
Pneumonia (bacteria, virus, fungus, PCP, etc.)
Aspiration (gastric acid, near drowning)
Neurogenic pulmonary edema
Embolism (VTE, amniotic, tumor, etc.)
Drugs (amiodarone, opiates, chemotherapeutics, etc.)
Shock
Trauma
Acute pancreatitis
Reperfusion injury
Acute upper airway obstruction
Hematologic (TRALI)
Optional diagnostic procedures:
Patient history (drugs, trauma, transfusions, etc.)
Bronchoscopy / tracheal secretions
Exclude: Cardiac ischemia (TnT↑,T n I ↑), Cardiac failure / TACO (BNP↑)
(depending on the assumed ARDS-Trigger)
Indirect anamnesis
Hemoculture
Exclude allergic pathomechanisms:
Antiallergic prophylaxis (H1/H2-antihistaminergic-blockade, single shot glucocorticosteroid application)
Advanced therapeutic measures:
Invasive ventilation regime according to ARDSnet
protocol (VT6mL/k PBW, best PEEP, BIPAP)
Goals: PaO2 55–80mmHg or SaO2 88–95%
Pinsp < 30cm H2O, pH 7.30–7.45
Novalung  (Persisting Pinsp↑, hypercapnia, hypoxia)
Therapy depending on Trigger (antibiotics, surgical
procedures, etc.)
Adjuvant intensive care handling:
Daily spontaneous breathing test
Daily stop of sedation
Avoid muscular relaxation
Elevate upper body
Thrombosis-Prophylaxis
Stress ulcer-Prophylaxis
Early enteral nutrition
Think about: rescue therapies
Inhaled nitric oxide, inhaled prostaglandins
Prolonged glucocorticosteroid application
Open lung ventilation (recruitment maneuvers)
Prone position
Surfactant replacement
ECMO
Legends:
PBW ( = Predicted body weight)
-M e n :5 0+0 .91 (body height (cm) 152.4)
-W o m e n :4 5 .5+0.91 (body height (cm) 152.4)
Brenner, Bopp, Hofer
Version 1.0 -November 2009
UniversityHospital Heidelberg
Figure 4: Standard operating procedure (SOP) of the Department of Anesthesiology, University of Heidelberg, Germany, for the diagnosis
and management of patients with suspected ARDS.
Additionally, as a result of this case and the diﬀerent, in
some parts, controversially discussed therapeutical options
available for ARDS, we introduced a new algorithm (stan-
dard operating procedure (SOP) of the Department of
Anesthesiology (University of Heidelberg, Germany)) for the
diagnosis and management of patients with suspected ARDS
(Figure 4).
3. Conclusions
Patients with preoperative cytoreductive chemotherapy
using potentially pneumonitis-inducing agents prior to the
surgicalprocedure should be intensively monitored concern-
ingtheirpulmonaryfunctionundergeneralanesthesia.First,
strongly elevated inspired oxygen fraction concentrations8 Anesthesiology Research and Practice
may be a potential risk for an “inﬂammatory burst” of
immune cells in the lung leading to an ARDS and should,
therefore,be avoided wheneverpossible. Secondly, oneneeds
to reduce to a minimum the surgeon’s contribution to the
ARDS-onsetthroughintensivetumormanipulationspriorto
resection resulting in massive cytokine liberation.
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Abbreviation List
ALI: Acute lung injury
ARDS: Acute respiratory distress syndrome
BNP: Brain natriuretic peptide
CT: Computed tomography
ECMO: Extracorporeal membrane oxygenation
FEV1: Forced expiratory vital capacity within 1 second
ICU: Intensive care unit
IU: International units
NSCLC: Non-small-cell lung cancer
PBW: Predicted body weight
PEEP: Positive endexpiratory pressure
PICCO: Pulse contour cardiac output
SOP: Standard operating procedure
TACO: Transfusion associated cardiac overload
TnI: Troponine I
TnT: Troponine T
TRALI: Transfusion-related acute lung injury
UFH: Unfractionated heparin
VC: Vital capacity
VR: Ventilator rate
VT: Tidal volume.
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